Moderna’s stock has rallied on hantavirus research that is ‘early-stage’ in nature
The biotech company a pre-clinical program with the U.S. Army and a vaccine center at a Korean university.
Original Source
Read the full article at Marketwatch →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.